Carregant...
An Exon Signature to Estimate the Tumor Mutational Burden of Right-sided Colon Cancer Patients
The clinical applicability of the whole-exome sequencing (WES) in estimating tumor mutational burden (TMB) is currently limited by high cost, time-consuming and tissue availability. And given to the differences in the mutational landscapes among different types of cancer, we aimed to develop a cance...
Guardat en:
| Publicat a: | J Cancer |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ivyspring International Publisher
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6959028/ https://ncbi.nlm.nih.gov/pubmed/31949492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.34363 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|